Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:73  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 
This article has been cited by
1Synthesis of Novel Quaternary Ammonium Salts and Their in Vitro Antileishmanial Activity and U-937 Cell Cytotoxicity
Sandra Duque-Benítez,Luz Ríos-Vásquez,Rogelio Ocampo-Cardona,David Cedeño,Marjorie Jones,Iván Vélez,Sara Robledo
Molecules.2016;21(4)381
[DOI]
2Innate Immunity and Leishmania Vaccination Strategies
Ron Birnbaum,Noah Craft
Dermatologic Clinics.2011;29(1)89
[DOI]
3Vaccination model for visceral leishmaniasis with infective immigrants
Ibrahim M. ELmojtaba,J.Y.T. Mugisha,Mohsin H.A. Hashim
Mathematical Methods in the Applied Sciences.2013;36(2)216
[DOI]
4Ultradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis Antigens
Leticia H. Higa,Laura Arnal,Mónica Vermeulen,Ana Paula Perez,Priscila Schilrreff,Cecilia Mundiña-Weilenmann,Osvaldo Yantorno,María Elena Vela,María José Morilla,Eder Lilia Romero,Bhaskar Saha
PLOS ONE.2016;11(3)e0150185
[DOI]
5IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis
Ciara Gimblet,Michael A. Loesche,Lucas Carvalho,Edgar M. Carvalho,Elizabeth A. Grice,David Artis,Phillip Scott,Simona Stäger
PLOS ONE.2015;10(8)e0134698
[DOI]
6Immune signal transduction in leishmaniasis from natural to artificial systems: Role of feedback loop insertion
Milsee Mol,Milind S. Patole,Shailza Singh
Biochimica et Biophysica Acta (BBA) - General Subjects.2014;1840(1)71
[DOI]
7Leishmaniasis: complexity at the host–pathogen interface
Paul Kaye,Phillip Scott
Nature Reviews Microbiology.2011;9(8)604
[DOI]
8Ethanolic leaf extract of Coccinia grandis is effective against both drug resistant and drug sensitive clinical isolates of Indian Kala-azar
Sangita Lahiry,Anjan K. Das,Sachindra N. Das,Madhumita Manna
Journal of Parasitic Diseases.2018;42(3)433
[DOI]
9Attenuated Leishmania induce pro-inflammatory mediators and influence leishmanicidal activity by p38 MAPK dependent phagosome maturation in Leishmania donovani co-infected macrophages
Somenath Banerjee,Dipayan Bose,Nabanita Chatterjee,Subhadip Das,Sreeparna Chakraborty,Tanya Das,Krishna Das Saha
Scientific Reports.2016;6(1)433
[DOI]
10Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach
Manju Kashyap,Varun Jaiswal,Umar Farooq
Infection, Genetics and Evolution.2017;53(1)107
[DOI]
11Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection
S.A. Campbell,J. Alawa,B. Doro,F.L. Henriquez,C.W. Roberts,A. Nok,C.B.I. Alawa,M. Alsaadi,A.B. Mullen,K.C. Carter
Vaccine.2012;30(7)1357
[DOI]
12Enlarging the chemical space of anti-leishmanials: a structure–activity relationship study of peptoids against Leishmania mexicana, a causative agent of cutaneous leishmaniasis
H. L. Bolt,G. A. Eggimann,Paul W. Denny,Steven L. Cobb
MedChemComm.2016;7(5)799
[DOI]
13Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
Guillermo Arango Duque,Albert Descoteaux
Frontiers in Immunology.2014;5(5)799
[DOI]
14Proteome-scale identification of Leishmania infantum for novel vaccine candidates: A hierarchical subtractive approach
Bahareh Vakili,Navid Nezafat,Gholam Reza Hatam,Bijan Zare,Nasrollah Erfani,Younes Ghasemi
Computational Biology and Chemistry.2018;72(5)16
[DOI]
15A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum
L. Pirdel,S. Farajnia
Scandinavian Journal of Immunology.2017;86(1)15
[DOI]
16Innate immunity againstLeishmaniainfections
Prajwal Gurung,Thirumala-Devi Kanneganti
Cellular Microbiology.2015;17(9)1286
[DOI]
17Innate immunity againstLeishmaniainfections
Shishir K. Gupta,Thomas Dandekar
Cellular Microbiology.2018;17(9)297
[DOI]
18Th17 cells and neutrophils: Close collaborators in chronic Leishmania mexicana infections leading to disease severity
C. P. Pedraza-Zamora,J. Delgado-Domínguez,J. Zamora-Chimal,I. Becker
Parasite Immunology.2017;39(4)e12420
[DOI]
19Chronic infection by Leishmania amazonensis mediated through MAPK ERK mechanisms
Pedro A. Martinez,Christine A. Petersen
Immunologic Research.2014;59(1-3)153
[DOI]
20Chronic infection by Leishmania amazonensis mediated through MAPK ERK mechanisms
Dulcilene Mayrink de Oliveira,Jonatan Marques Campos,Soraia de Oliveira Silva,Maria Norma Melo
Immunologic Research.2019;59(1-3)153
[DOI]
21Pomegranate (Punica granatum) Juice Shows Antioxidant Activity against Cutaneous Leishmaniasis-Induced Oxidative Stress in Female BALB/c Mice
Badriah Alkathiri,Manal El-Khadragy,Dina Metwally,Ebtesam Al-Olayan,Muhammed Bakhrebah,Ahmed Abdel Moneim
International Journal of Environmental Research and Public Health.2017;14(12)1592
[DOI]
22Countervailing, time-dependent effects on host autophagy promote intracellular survival ofLeishmania
Sneha A. Thomas,Devki Nandan,Jennifer Kass,Neil E. Reiner
Journal of Biological Chemistry.2018;293(7)2617
[DOI]
23Actualités sur les leishmanioses viscérales
B. Faucher,R. Piarroux
La Revue de Médecine Interne.2011;32(9)544
[DOI]
24Actualités sur les leishmanioses viscérales
Pedro Cecílio,Fabiano Oliveira,Anabela Cordeiro da Silva
La Revue de Médecine Interne.2018;32(9)544
[DOI]
25Investigating the Anti-leishmanial Effects of Linear Peptoids
Gabriela A. Eggimann,Hannah L. Bolt,Paul W. Denny,Steven L. Cobb
ChemMedChem.2015;10(2)233
[DOI]
26Intralesional uridine-5'-triphosphate (UTP) treatment induced resistance to Leishmania amazonensis infection by boosting Th1 immune responses and reactive oxygen species production
Camila Marques-da-Silva,Mariana M. Chaves,Maria Luiza Thorstenberg,Vanessa R. Figliuolo,Flávia S. Vieira,Suzana P. Chaves,José Roberto Meyer-Fernandes,Bartira Rossi-Bergmann,Luiz Eduardo Baggio Savio,Robson Coutinho-Silva
Purinergic Signalling.2018;14(2)201
[DOI]
27Investigation of antileishmanial activities of Tio2@Ag nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro
Adil M. Allahverdiyev,Emrah Sefik Abamor,Melahat Bagirova,Serap Yesilkir Baydar,Sezen Canim Ates,Figen Kaya,Cengiz Kaya,Miriam Rafailovich
Experimental Parasitology.2013;135(1)55
[DOI]
28FOXP3 expression and frequency of regulatory T cells in healed individuals from Leishmania major infection and the asymptomatic cases
Fariborz Bahrami,Haiedeh Darabi,Farhad Riazi-Rad,Vahid Khaze,Soheila Ajdary,Mohammad Hossein Alimohammadian
Human Immunology.2014;75(10)1026
[DOI]
29FOXP3 expression and frequency of regulatory T cells in healed individuals from Leishmania major infection and the asymptomatic cases
Bhavana Sethu Lakshmi,Rentala Madhubala
Human Immunology.2013;75(10)143
[DOI]
30Leishmaniasis cutánea
Julián Díaz Sánchez,Sagrario Barrientos Serrano,Silvia Morell Mañas
FMC - Formación Médica Continuada en Atención Primaria.2012;19(3)117
[DOI]
31Exploring the Role of Medicinal Plant-Based Immunomodulators for Effective Therapy of Leishmaniasis
Garima Chouhan,Mohammad Islamuddin,Dinkar Sahal,Farhat Afrin
Frontiers in Immunology.2014;5(3)117
[DOI]
32An NLRP3 inflammasome–triggered Th2-biased adaptive immune response promotes leishmaniasis
Prajwal Gurung,Rajendra Karki,Peter Vogel,Makiko Watanabe,Mark Bix,Mohamed Lamkanfi,Thirumala-Devi Kanneganti
Journal of Clinical Investigation.2015;125(3)1329
[DOI]
33Leishmania donovani inhibits inflammasome-dependent macrophage activation by exploiting the negative regulatory proteins A20 and UCP2
Anand Kumar Gupta,Kuntal Ghosh,Shreyasi Palit,Jayita Barua,Pijush K. Das,Anindita Ukil
The FASEB Journal.2017;31(11)5087
[DOI]
34Cheminformatic models based on machine learning for pyruvate kinase inhibitors of Leishmania mexicana
Salma Jamal,Vinod Scaria
BMC Bioinformatics.2013;14(1)5087
[DOI]
35Apoptotic induction induces Leishmania aethiopica and L. mexicana spreading in terminally differentiated THP-1 cells
RAJEEV RAI,PAUL DYER,SIMON RICHARDSON,LAURENCE HARBIGE,GIULIA GETTI
Parasitology.2017;144(14)1912
[DOI]
36A Perspective on the Emergence of Sialic Acids as Potent Determinants AffectingLeishmaniaBiology
Angana Ghoshal,Chitra Mandal
Molecular Biology International.2011;2011(14)1
[DOI]
37Immunogenicity and Efficacy of Polytope DNA Vaccine Against Cutaneous Leishmaniosis In Vivo
Reza Keikha,Mojgan Bandehpour,Shabnam Jeibouei,Bahram Kazemi
Health Scope.2017;7(1)1
[DOI]
38Head-to-Head Comparison of Three Vaccination Strategies Based on DNA and Raw Insect-Derived Recombinant Proteins against Leishmania
Felicitat Todolí,Alhelí Rodríguez-Cortés,María del Carmen Núñez,Márcia D. Laurenti,Silvia Gómez-Sebastián,Fernando Rodríguez,Eva Pérez-Martín,José M. Escribano,Jordi Alberola,Anil Kumar Tyagi
PLoS ONE.2012;7(12)e51181
[DOI]
39Nucleolar Localization of RNA Binding Proteins Induced by Actinomycin D and Heat Shock in Trypanosoma cruzi
Ezequiel Názer,Ramiro E. Verdún,Daniel O. Sánchez,Mauricio Martins Rodrigues
PLoS ONE.2011;6(5)e19920
[DOI]
40A Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8+ T Cells
Mithun Maji,Saumyabrata Mazumder,Souparno Bhattacharya,Somsubhra Thakur Choudhury,Abdus Sabur,Md. Shadab,Pradyot Bhattacharya,Nahid Ali
Scientific Reports.2016;6(1)e19920
[DOI]
41A Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8+ T Cells
Joachim Kloehn,Eleanor C. Saunders,Malcolm J. McConville
Scientific Reports.2016;6(1)83
[DOI]
42Preparation of highly infective Leishmania promastigotes by cultivation on SNB-9 biphasic medium
Igor Grekov,Milena Svobodová,Eva Nohýnková,Marie Lipoldová
Journal of Microbiological Methods.2011;87(3)273
[DOI]
43The impact of distinct culture media in Leishmania infantum biology and infectivity
NUNO SANTARÉM,JOANA CUNHA,RICARDO SILVESTRE,CÁTIA SILVA,DIANA MOREIRA,MARC OUELLETTE,ANABELA CORDEIRO-DA-SILVA
Parasitology.2014;141(2)192
[DOI]
44A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study
Jyoti Joshi,Nancy Malla,Sukhbir Kaur
Parasitology International.2014;63(4)612
[DOI]
45A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study
Angela Casini,Andreia de Almeida
Parasitology International.2016;63(4)297
[DOI]
46Anti-parasitic Peptides from Arthropods and their Application in Drug Therapy
Ariane F. Lacerda,Patrícia B. Pelegrini,Daiane M. de Oliveira,Érico A. R. Vasconcelos,Maria F. Grossi-de-Sá
Frontiers in Microbiology.2016;7(4)297
[DOI]
47Leishmania recombinant antigen modulates macrophage effector function facilitating early clearance of intracellular parasites
Anuradha Ratna,Sunil K Arora
Transactions of The Royal Society of Tropical Medicine and Hygiene.2016;110(10)610
[DOI]
48Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis
Toni Aebischer
Frontiers in Immunology.2014;5(10)610
[DOI]
49ANIMAL MODELS FOR THE STUDY OF LEISHMANIASIS IMMUNOLOGY
Elsy Nalleli Loria-Cervera,Fernando Jose Andrade-Narvaez
Revista do Instituto de Medicina Tropical de São Paulo.2014;56(1)1
[DOI]
50Interactions betweenLeishmania braziliensisand Macrophages Are Dependent on the Cytoskeleton and Myosin Va
Elisama Azevedo,Leandro Teixeira Oliveira,Ana Karina Castro Lima,Rodrigo Terra,Patrícia Maria Lourenço Dutra,Verônica P. Salerno
Journal of Parasitology Research.2012;2012(1)1
[DOI]
51GTPase Sar1 regulates the trafficking and secretion of the virulence factor gp63 inLeishmania
Smriti Parashar,Amitabha Mukhopadhyay
Journal of Biological Chemistry.2017;292(29)12111
[DOI]
52Nigella sativa oil entrapped polycaprolactone nanoparticles for leishmaniasis treatment
Emrah Sefik Abamor,Ozlem Ayse Tosyali,Melahat Bagirova,Adil Allahverdiyev
IET Nanobiotechnology.2018;12(8)1018
[DOI]
53Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites
Angamuthu Selvapandiyan,Ranadhir Dey,Sreenivas Gannavaram,Ines Lakhal-Naouar,Robert Duncan,Poonam Salotra,Hira L. Nakhasi
Journal of Tropical Medicine.2012;2012(8)1
[DOI]
54Interactions of antiparasitic alkaloids with Leishmania protein targets: a molecular docking analysis
Ifedayo Victor Ogungbe,Joseph D Ng,William N Setzer
Future Medicinal Chemistry.2013;5(15)1777
[DOI]
55Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine
Negar Seyed,Tahereh Taheri,Charline Vauchy,Magalie Dosset,Yann Godet,Ali Eslamifar,Iraj Sharifi,Olivier Adotevi,Christophe Borg,Pierre Simon Rohrlich,Sima Rafati,Clive M. Gray
PLoS ONE.2014;9(10)e108848
[DOI]
56Identifying vaccine targets for anti-leishmanial vaccine development
Shyam Sundar,Bhawana Singh
Expert Review of Vaccines.2014;13(4)489
[DOI]
57Single Dose Novel Salmonella Vaccine Enhances Resistance against Visceralizing L. major and L. donovani Infection in Susceptible BALB/c Mice
Juliane Schroeder,Najmeeyah Brown,Paul Kaye,Toni Aebischer,Diane McMahon-Pratt
PLoS Neglected Tropical Diseases.2011;5(12)e1406
[DOI]
58Using proteomics as a powerful tool to develop a vaccine against Mediterranean visceral leishmaniasis
Sajad Rashidi,Kurosh Kalantar,Gholamreza Hatam
Journal of Parasitic Diseases.2018;42(2)162
[DOI]
59Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends
Ali Badiee,Vahid Heravi Shargh,Ali Khamesipour,Mahmoud Reza Jaafari
Vaccine.2013;31(5)735
[DOI]
60TLR-mediated distinct IFN-?/IL-10 pattern induces protective immunity against murine visceral leishmaniasis
Joydeep Paul,Subir Karmakar,Tripti De
European Journal of Immunology.2012;42(8)2087
[DOI]
61In Silico Analysis of Six Known Leishmania major Antigens and In Vitro Evaluation of Specific Epitopes Eliciting HLA-A2 Restricted CD8 T Cell Response
Negar Seyed,Farnaz Zahedifard,Shima Safaiyan,Elham Gholami,Fatemeh Doustdari,Kayhan Azadmanesh,Maryam Mirzaei,Nasir Saeedi Eslami,Akbar Khadem Sadegh,Ali Eslami far,Iraj Sharifi,Sima Rafati,Hechmi Louzir
PLoS Neglected Tropical Diseases.2011;5(9)e1295
[DOI]
62Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains
Dirlei Nico,Daniele Crespo Gomes,Marcus Vinícius Alves-Silva,Elisangela Oliveira Freitas,Alexandre Morrot,Diana Bahia,Marcos Palatnik,Mauricio M. Rodrigues,Clarisa B. Palatnik-de-Sousa
Frontiers in Immunology.2014;5(9)e1295
[DOI]
63Efficacy of Recombinant Canine Distemper Virus Expressing Leishmania Antigen against Leishmania Challenge in Dogs
Ryuichi Miura,Takanori Kooriyama,Misako Yoneda,Akiko Takenaka,Miho Doki,Yasuyuki Goto,Chizu Sanjoba,Yasuyuki Endo,Tomoko Fujiyuki,Akihiro Sugai,Kyoko Tsukiyama-Kohara,Yoshitsugu Matsumoto,Hiroki Sato,Chieko Kai,Ricardo Toshio Fujiwara
PLOS Neglected Tropical Diseases.2015;9(7)e0003914
[DOI]
64Identification and expression of a new member of the pyrokinin/pban gene family in the sand fly Phlebotomus papatasi
Man-Yeon Choi,Neil D. Sanscrainte,Alden S. Estep,Robert K. Vander Meer,James J. Becnel
Journal of Insect Physiology.2015;79(7)55
[DOI]
65Proteoliposomes in nanobiotechnology
P. Ciancaglini,A. M. S. Simão,M. Bolean,J. L. Millán,C. F. Rigos,J. S. Yoneda,M. C. Colhone,R. G. Stabeli
Biophysical Reviews.2012;4(1)67
[DOI]
66Substrate Preferences and Catalytic Parameters Determined by Structural Characteristics of Sterol 14a-Demethylase (CYP51) fromLeishmania infantum
Tatiana Y. Hargrove,Zdzislaw Wawrzak,Jialin Liu,W. David Nes,Michael R. Waterman,Galina I. Lepesheva
Journal of Biological Chemistry.2011;286(30)26838
[DOI]
67Substrate Preferences and Catalytic Parameters Determined by Structural Characteristics of Sterol 14a-Demethylase (CYP51) fromLeishmania infantum
Ranadhir Dey,Sreenivas Gannavaram,Angamuthu Selvapandiyan,Jacqueline Fiuza,Robert Duncan,Hira L. Nakhasi
Journal of Biological Chemistry.2014;286(30)45
[DOI]
68Immunization against Leishmania major Infection Using LACK- and IL-12-Expressing Lactococcus lactis Induces Delay in Footpad Swelling
Felix Hugentobler,Karen K. Yam,Joshua Gillard,Raya Mahbuba,Martin Olivier,Benoit Cousineau,Dan Zilberstein
PLoS ONE.2012;7(2)e30945
[DOI]
69Metabolomic Analyses of Leishmania Reveal Multiple Species Differences and Large Differences in Amino Acid Metabolism
Gareth D. Westrop,Roderick A. M. Williams,Lijie Wang,Tong Zhang,David G. Watson,Ana Marta Silva,Graham H. Coombs,Bhaskar Saha
PLOS ONE.2015;10(9)e0136891
[DOI]
70Leishmania genome analysis and high-throughput immunological screening identifies tuzin as a novel vaccine candidate against visceral leishmaniasis
Bhavana Sethu Lakshmi,Ruobing Wang,Rentala Madhubala
Vaccine.2014;32(30)3816
[DOI]
71Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches
Sumit Joshi,Keerti Rawat,Narendra Kumar Yadav,Vikash Kumar,Mohammad Imran Siddiqi,Anuradha Dube
Frontiers in Immunology.2014;5(30)3816
[DOI]
72Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection
Felix Hugentobler,Raphaël B. Di Roberto,Joshua Gillard,Benoit Cousineau
Vaccine.2012;30(39)5726
[DOI]
73Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection
Ifedayo V. Ogungbe,Meenakshi Singh,William N. Setzer
Vaccine.2012;36(39)331
[DOI]
74Isobenzofuranone derivatives exhibit antileishmanial effect by inhibiting type II DNA topoisomerase and inducing host response
Amartya Mishra,Jayaraman Vinayagam,Sourav Saha,Sayan Chowdhury,Somenath Roychowdhury,Parasuraman Jaisankar,Hemanta K. Majumder
Pharmacology Research & Perspectives.2014;2(6)e00070
[DOI]
75Development of a new live attenuated Leishmania major p27 gene knockout: Safety and immunogenicity evaluation in BALB/c mice
Samira Elikaee,Mehdi Mohebali,Sassan Rezaei,Hamid Eslami,Ali Khamesipour,Hossein Keshavarz,Mohammad Reza Eshraghian
Cellular Immunology.2018;332(6)24
[DOI]
76Comparison of immunogenical potency of Leishmania major (MRHO/IR/75/ER) antigens prepared by 3 different methods in conjunction with Alum-Naltrexone adjuvant in BALB/c mice
Peyman Khezri,Shahram Shahabi,Esmaeil Abasi,Habib Mohammadzadeh Hajipirloo
Alexandria Journal of Medicine.2018;54(4)503
[DOI]
77Proteome Profiling of Human Cutaneous Leishmaniasis Lesion
Claire da Silva Santos,Sanaz Attarha,Ravi Kanth Saini,Viviane Boaventura,Jackson Costa,Ricardo Khouri,Manoel Barral-Netto,Cláudia Ida Brodskyn,Serhiy Souchelnytskyi
Journal of Investigative Dermatology.2015;135(2)400
[DOI]
78Metabolic Variation during Development in Culture of Leishmania donovani Promastigotes
Ana Marta Silva,Anabela Cordeiro-da-Silva,Graham H. Coombs,Genevieve Milon
PLoS Neglected Tropical Diseases.2011;5(12)e1451
[DOI]
79Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against Leishmania major -infected BALB/c mice
H. Montakhab-Yeganeh,Z. Abdossamadi,F. Zahedifard,Y. Taslimi,A. Badirzadeh,N. Saljoughian,T. Taheri,M. Taghikhani,S. Rafati
Parasite Immunology.2017;39(10)e12461
[DOI]
80Spatiotemporal and molecular epidemiology of cutaneous leishmaniasis in Libya
Ahmad Amro,Hamida Al-Dwibe,Aisha Gashout,Olga Moskalenko,Marlena Galafin,Omar Hamarsheh,Marcus Frohme,Anja Jaeschke,Gabriele Schönian,Katrin Kuhls,Anne-Laure Bañuls
PLOS Neglected Tropical Diseases.2017;11(9)e0005873
[DOI]
81Investigation of the antimicrobial activity of a short cationic peptide against promastigote and amastigote forms of Leishmania major (MHRO/IR/75/ER): An in vitro study
Sara khalili,Elahe Ebrahimzade,Mehdi Mohebali,Parviz Shayan,Samira Mohammadi-Yeganeh,Mehrdad Moosazadeh Moghaddam,Samira Elikaee,Behnaz Akhoundi,Mohammad Kazem Sharifi-Yazdi
Experimental Parasitology.2019;196(9)48
[DOI]
82Characterization of Leishmania infantum thiol-dependent reductase 1 and evaluation of its potential to induce immune protection
A. M. SILVA,J. TAVARES,R. SILVESTRE,A. OUAISSI,G. H. COOMBS,A. CORDEIRO-da-SILVA
Parasite Immunology.2012;34(6)345
[DOI]
83Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins
Maria Agallou,Evita Athanasiou,Olga Koutsoni,Eleni Dotsika,Evdokia Karagouni
Frontiers in Immunology.2014;5(6)345
[DOI]
84Alternative to Chemotherapy—The Unmet Demand against Leishmaniasis
Nicky Didwania,Md. Shadab,Abdus Sabur,Nahid Ali
Frontiers in Immunology.2017;8(6)345
[DOI]
85The Economic Value of a Visceral Leishmaniasis Vaccine in Bihar State, India
Diana L. Connor,Rachel B. Slayton,Mirat Shah,Sara Beth Kitchen,Bruce Y. Lee,Kristina M. Bacon
The American Journal of Tropical Medicine and Hygiene.2012;86(3)417
[DOI]
86Application of nanotechnology in treatment of leishmaniasis: A Review
Maryam Akbari,Ahmad Oryan,Gholamreza Hatam
Acta Tropica.2017;172(3)86
[DOI]
87Cytosolic Recognition of Microbes and Pathogens: Inflammasomes in Action
Jenni A. Hayward,Anukriti Mathur,Chinh Ngo,Si Ming Man
Microbiology and Molecular Biology Reviews.2018;82(4)86
[DOI]
88KSAC, a Defined Leishmania Antigen, plus Adjuvant Protects against the Virulence of L. major Transmitted by Its Natural Vector Phlebotomus duboscqi
Regis Gomes,Clarissa Teixeira,Fabiano Oliveira,Phillip G. Lawyer,Dia-Eldin Elnaiem,Claudio Meneses,Yasuyuki Goto,Ajay Bhatia,Randall F. Howard,Steven G. Reed,Jesus G. Valenzuela,Shaden Kamhawi,Ben L. Kelly
PLoS Neglected Tropical Diseases.2012;6(4)e1610
[DOI]
89Liposomal Elongation Factor-1a Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis
Abdus Sabur,Sudipta Bhowmick,Rudra Chhajer,Sarfaraz Ahmad Ejazi,Nicky Didwania,Mohammad Asad,Anirban Bhattacharyya,Utsa Sinha,Nahid Ali
Frontiers in Immunology.2018;9(4)e1610
[DOI]
90Visceral leishmaniasis: An overview of vaccine adjuvants and their applications
Sneha Ratnapriya,Sneha Keerti,Amogh A. Sahasrabuddhe,Anuradha Dube
Vaccine.2019;37(27)3505
[DOI]
91Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity
A. K. Marr,S. Cen,R. E. W. Hancock,W. R. McMaster
Antimicrobial Agents and Chemotherapy.2016;60(4)2484
[DOI]
92Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors
Prajwal Gurung,Thirumala-Devi Kanneganti
Cellular and Molecular Life Sciences.2016;73(16)3035
[DOI]
93Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis
Sneha Anand,Rentala Madhubala
Scientific Reports.2015;5(1)3035
[DOI]
94Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art
REBECCA L. CHARLTON,BARTIRA ROSSI-BERGMANN,PAUL W. DENNY,PATRICK G. STEEL
Parasitology.2018;145(2)219
[DOI]
95Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido[3,4-b]indole derivatives as anti-leishmanial agents
Penta Ashok,Subhash Chander,Terry K. Smith,Rajnish Prakash Singh,Prabhat Nath Jha,Murugesan Sankaranarayanan
Bioorganic Chemistry.2019;84(2)98
[DOI]
96Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido[3,4-b]indole derivatives as anti-leishmanial agents
Vincent R. Bonagura
Bioorganic Chemistry.2014;84(2)845
[DOI]
97Visceral leishmaniasis: immunology and prospects for a vaccine
P.M. Kaye,T. Aebischer
Clinical Microbiology and Infection.2011;17(10)1462
[DOI]
98Leishmania infantum Asparagine Synthetase A Is Dispensable for Parasites Survival and Infectivity
Joana Faria,Inês Loureiro,Nuno Santarém,Sandra Macedo-Ribeiro,Joana Tavares,Anabela Cordeiro-da-Silva,Michael Pollastri
PLOS Neglected Tropical Diseases.2016;10(1)e0004365
[DOI]
99Leishmaniasis in the Middle East: Incidence and Epidemiology
Nasir Salam,Waleed Mohammed Al-Shaqha,Arezki Azzi,Elodie Ghedin
PLoS Neglected Tropical Diseases.2014;8(10)e3208
[DOI]
  Addresses 
  My Preferences 


JGID
JGID
What's new
Forthcoming Symposia
Submit articles
Email alerts
Join us
Most popular articles
Recommend this journal
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008